Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Integra Artifical Skin receives CE Mark certification

March 27, 1998

Phase III trials of Microsponge-entrapped 5-FU begin in the U.S.

March 27, 1998

New retinoid-like compounds discovered at Allergan

March 25, 1998

Life Medical Sciences receives FDA approval to begin Repel-CV trials

March 25, 1998

FK-506: a topical agent for the treatment of moderate to severe atopic dermatitis

March 25, 1998

Positive trial results reported for AlloDerm

March 24, 1998

Potential new indication for zafirlukast in the treatment of urticaria

March 23, 1998

PSSO: an alternative to hydrocortisone for the treatment of erythema

March 23, 1998

Schering-Plough and Chugai sign marketing agreement for psoriasis drug

March 20, 1998

Botox effective in controlling focal hyperhidrosis

March 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...